Many biotech and pharmaceutical firm won't gain much from the new corporate tax rate, but they'll benefit from being able to access overseas cash. (cnbc.com)
The iPhone maker will pay $ 38 bln in tax on its huge pile of overseas cash. (breakingviews.com)
The U.S. tax system overhaul also has created incentives for companies to repatriate overseas cash currently held in short - term instruments. (businessinsider.com)